Strategic partnerships Leverage existing and upcoming collaborations with large health systems (Memorial Hermann, MedStar Health, Tampa General) to position Reimagine Care as the scalable at‑home oncology care platform that expands capacity, reduces after-hours burden, and improves patient outcomes for enterprise buyers.

Expansion momentum Capitalize on rapid growth signals from 2025–2026 partnerships and technology upgrades (Remi AI enhancements, CAR‑T support) to target health systems seeking to scale precision oncology delivery and remote patient management with AI‑assisted care.

Enterprise value Highlight the financial and operational benefits for providers: reduced avoidable ER visits, lower administrative load, preserved clinician joy, and expanded reach through AI‑enabled virtual oncology care that fits within hospital networks and oncology practices.

AI powered care Position Remi and the AI platform as a differentiator for cancer centers pursuing advanced digital health strategies, emphasizing large language model capabilities, safety protections, and outpatient support for complex therapies like CAR‑T outside the hospital setting.

Market potential Target mid to large health systems and cancer institutes seeking scalable care at home; with revenue in the tens of millions and a balanced funding backdrop, present a compelling ROI story to CIOs, CMOs, and VP of Oncology Services.